EUVIMEDEUVIMED entdecken
Crossref

Cabtreo: A Three-Drug Gel for Acne

The Medical Letter on Drugs and Therapeutics · 2024

DOI: 10.58347/tml.2024.1700b ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2024. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatologic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FDA has approved Cabtreo (Bausch Health), a gel containing the retinoid adapalene, the oxidizing agent benzoyl peroxide, and the antibiotic clindamycin, for treatment of acne vulgaris in patients ≥12 years old. Cabtreo is the first three-drug topical formulation to become available in the US for treatment of acne.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisDermatologic AgentsHumansGelsAdapaleneBenzoyl PeroxideDrug CombinationsClindamycin

Stichwörter der Autor:innen

AcanyaCabtreoCleocinDifferinEpiduoEvoclinNeuacOnextonacneadapaleneadverse effectsbenzoyl peroxideclindamycindosagedrug interactions

Substanzen

Dermatologic AgentsGelsAdapaleneBenzoyl PeroxideDrug CombinationsClindamycin

Zitieren

APA

(2024). Cabtreo: A Three-Drug Gel for Acne. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2024.1700b

Vancouver

Cabtreo: A Three-Drug Gel for Acne. The Medical Letter on Drugs and Therapeutics. 2024. doi:10.58347/tml.2024.1700b

BibTeX
@article{euvimed2024,
  title = {Cabtreo: A Three-Drug Gel for Acne},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2024},
  doi = {10.58347/tml.2024.1700b}
}
Kostenlos starten →